{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:15:08Z","timestamp":1777882508589,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K12891"],"award-info":[{"award-number":["22K12891"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Therapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.reth.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:11:34Z","timestamp":1752613894000},"page":"384-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessment of the official national insurance coverage of regenerative medical products for ophthalmic diseases in Japan following regulatory approval"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1793-0721","authenticated-orcid":false,"given":"Kenichi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morio","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reth.2025.07.003_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/2168479014526877","article-title":"New governmental regulatory system for stem cell-based therapies in Japan","volume":"48","author":"Hara","year":"2014","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.reth.2025.07.003_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.stem.2015.03.012","article-title":"New Japanese initiatives on stem cell therapies","volume":"16","author":"Konomi","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.reth.2025.07.003_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reth.2016.04.001","article-title":"Japan's challenges of translational regenerative medicine: act on the safety of regenerative medicine","volume":"4","author":"Tobita","year":"2016","journal-title":"Regen Ther"},{"key":"10.1016\/j.reth.2025.07.003_bib5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reth.2025.07.003_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jtos.2023.05.008","article-title":"Insights into the clinical development of regenerative medical products through a comparison of three cell-based products recently approved for limbal stem cell deficiency","volume":"29","author":"Aketa","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.reth.2025.07.003_bib20","unstructured":"CynosBio, Inc. ABOUT US. https:\/\/cynosbio.com\/en\/about\/. Accessed 14 April 2025."},{"key":"10.1016\/j.reth.2025.07.003_bib21","unstructured":"Aurion Biotech Japan, LLC. About us (in Japanese). https:\/\/aurionbiotech.co.jp\/about.html. Accessed 14 April 2025."},{"key":"10.1016\/j.reth.2025.07.003_bib24","first-page":"804","article-title":"Criteria for use of neltependocel","volume":"127","year":"2023","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.reth.2025.07.003_bib25","first-page":"953","article-title":"Criteria for use of neltependocel, 2nd edition","volume":"128","year":"2024","journal-title":"Nippon Ganka Gakkai Zasshi"}],"container-title":["Regenerative Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320425001579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352320425001579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:14:09Z","timestamp":1777598049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352320425001579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":9,"alternative-id":["S2352320425001579"],"URL":"https:\/\/doi.org\/10.1016\/j.reth.2025.07.003","relation":{},"ISSN":["2352-3204"],"issn-type":[{"value":"2352-3204","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the official national insurance coverage of regenerative medical products for ophthalmic diseases in Japan following regulatory approval","name":"articletitle","label":"Article Title"},{"value":"Regenerative Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reth.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier BV on behalf of The Japanese Society for Regenerative Medicine.","name":"copyright","label":"Copyright"}]}}